Unknown

Dataset Information

0

Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.


ABSTRACT: Fusobacterium nucleatum (Fn) is an important tumour-associated bacterium in colorectal cancer (CRC). The antioxidant protein alkyl hydroperoxide reductase subunit C (AhpC) can induce strong antibacterial immune response during various pathogen infections. Our study aimed to evaluate the efficacy of Fn-AhpC as a candidate vaccine. In this work, by western blot analysis, we showed that Fn-AhpC recombinant protein could be recognized specifically by antibodies present in the sera of CRC patients; using the mouse Fn-infection model, we observed that systemic prophylactic immunization with AhpC/alum conferred significant protection against infection in 77.3% of mice. In addition, we measured the anti-AhpC antibody level in the sera of CRC patients and found that there was no obvious increase of anti-AhpC antibodies in the early-stage CRC group. Furthermore, we treated Fn with the sera from both immunized mice and CRC patients and found that sera with high anti-AhpC antibodies titre could inhibit Fn growth. In conclusion, our findings support the use of AhpC as a potential vaccine candidate against inhabitation or infection of Fn in the intestinal tract, which could provide a practical strategy for the prevention of CRC associated with Fn infection.

SUBMITTER: Guo SH 

PROVIDER: S-EPMC5585165 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.

Guo Song-He SH   Wang Hai-Fang HF   Nian Zhi-Gang ZG   Wang Yi-Dan YD   Zeng Qiu-Yao QY   Zhang Ge G  

Scientific reports 20170905 1


Fusobacterium nucleatum (Fn) is an important tumour-associated bacterium in colorectal cancer (CRC). The antioxidant protein alkyl hydroperoxide reductase subunit C (AhpC) can induce strong antibacterial immune response during various pathogen infections. Our study aimed to evaluate the efficacy of Fn-AhpC as a candidate vaccine. In this work, by western blot analysis, we showed that Fn-AhpC recombinant protein could be recognized specifically by antibodies present in the sera of CRC patients; u  ...[more]

Similar Datasets

| S-EPMC4549766 | biostudies-literature
| S-EPMC3675929 | biostudies-literature
| S-EPMC4338369 | biostudies-literature
| S-EPMC10530411 | biostudies-literature
| S-EPMC3909096 | biostudies-literature
| S-EPMC6607099 | biostudies-literature
| S-EPMC2794088 | biostudies-literature
| S-EPMC9239216 | biostudies-literature
| S-EPMC4384994 | biostudies-literature
| S-EPMC4249189 | biostudies-literature